Canadian Agency for Drugs and Technologies in Health
$265,276,781.00 CAD
- Department
- Health Canada
- Recipient country
- Canada
- Fiscal year
- 2023-2024
- Agreement period
- March 15, 2024 – March 31, 2029
- Reference
- hc-sc:271-2024-2025-Q4-00111
Published purpose
To enhance the health of Canadians and health system sustainability by promoting the cost-effective and optimal use of drugs and other health technologies.
In plain English AI-generated
This contribution supports the Canadian Agency for Drugs and Technologies in Health to promote cost-effective and optimal use of drugs and health technologies, aiming to improve health outcomes and system sustainability in Canada.
Category: Health Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.